American Heart Journal
Volume 144, Issue 6 , Pages 981-986 , December 2002

European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials

Received 29 August 2001 ,Accepted 15 February 2002.

References 

  1. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  2. Jaffe AS, Ravkilde J, Roberts R, et al.  It's time for a change to a troponin standard. Circulation. 2000;102:1216–1220
  3. Wu AH, Apple FS, Gibler WB, et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45:1104–1121
  4. Panteghini M, Apple FS, Christenson RH, et al.  Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest. 1999;230(Suppl):103–112
  5. Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem. 2001;47:377–379
  6. Kontos MC, Fritz ML, Anderson FP, et al.  Where do you draw the line? Implications of the new troponin standard on the prevalence of myocardial infarction [abstract]. Circulation. 2001;104:II709
  7. Gitt AK, Schiele R, Meiser F, et al.  Myocardial infarction redefined: implication of the new definition of non-ST-elevation myocardial infarction on clinical practice: results of the ACOS-registry [abstract]. Circulation. 2001;104:II709
  8. Johari V, Davis GK, Hoybook K, et al.  Retrospective database review for use of cardiac troponin I for detection of myocardial infarction [abstract]. Clin Chem. 2001;47:A212
  9. Christenson RH, Duh SH, Apple FS, et al.  Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem. 2001;47:431–437
  10. Panteghini M, Gerhardt W, Apple FS, et al.  Quality specification for cardiac troponin assays. Clin Chem Lab Med. 2001;39:174–178
  11. Christenson RH, Vaidya H, Landt Y, et al.  Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material. Clin Chem. 1999;45:1414–1423
  12. AHB W . Analytical issues affecting the clinical performance of cardiac troponin assays. In:  Adams A,  Apple FS,  Jaffe AS,  Wu AHB editor. Markers in cardiology: current and future clinical applications. Armonk (NY): : Futura; 2001;p. 1–12
  13. Ottani F, Galvani M, Nicolini FA, et al.  Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000;140:917–927
  14. Theroux P, Chaitman BR, Danchin N, et al.  Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: main results of the GUARDIAN trial. GUARD during Ischemia Against Necrosis. Circulation. 2000;102:3032–3038
  15. Apple FS, Murakami MM, Panteghini M, et al.  An international survey of cardiac troponin users. Clin Chem. 2001;47:587–588
  16. Lindahl B, Diderholm E, Lagerqvist B, et al.  Mechanisms behind the prognostic value of troponin in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38:979–986
  17. Chaitman BR, Jaffe AS. What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarification. Circulation. 1995;91:1609–1610
  18. Califf RM, Abdelmeguid AE, Kuntz RE, et al.  Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–251
  19. Pelletier LC, Carrier M, Leclerc Y, et al.  Intermittent antegrade warm versus cold blood cardioplegia: a prospective, randomized study. Ann Thorac Surg. 1994;58:41–49
  20. Katus HA, Schoeppenthau M, Tanzeem , et al.  Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin. Br Heart J. 1991;65:259–264
  21. Sadony V, Korber M, Albes G, et al.  Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;13:57–65
  22. Alyanakian MA, Dehoux M, Chatel D, et al.  Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. J Cardiothorac Vasc Anesth. 1998;12:288–294

☆ Reprint requests: Allan S. Jaffe, MD, 16th Floor, Mayo Building, 200 First Street SW, Rochester, MN 55905.

☆☆ E-mail: jaffe.allan@mayo.edu

PII: S0002-8703(02)00221-1

doi: 10.1067/mhj.2002.124048

American Heart Journal
Volume 144, Issue 6 , Pages 981-986 , December 2002

Article Tools

* Image Usage & Resolution